- Home
- ALDX vs XPOF Comparison
ALDX vs XPOF Comparison
Compare ALDX & XPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- XPOF
- Stock Information
- Founded
- ALDX 2004
- XPOF 2017
- Country
- ALDX United States
- XPOF United States
- Employees
- ALDX N/A
- XPOF N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- XPOF Services-Misc. Amusement & Recreation
- Sector
- ALDX Health Care
- XPOF Consumer Discretionary
- Exchange
- ALDX Nasdaq
- XPOF Nasdaq
- Market Cap
- ALDX 342.3M
- XPOF 302.9M
- IPO Year
- ALDX 2014
- XPOF 2021
- Fundamental
- Price
- ALDX $5.39
- XPOF $8.93
- Analyst Decision
- ALDX Strong Buy
- XPOF Buy
- Analyst Count
- ALDX 2
- XPOF 7
- Target Price
- ALDX $9.50
- XPOF $12.93
- AVG Volume (30 Days)
- ALDX 772.4K
- XPOF 598.6K
- Earning Date
- ALDX 11-06-2025
- XPOF 11-06-2025
- Dividend Yield
- ALDX N/A
- XPOF N/A
- EPS Growth
- ALDX N/A
- XPOF N/A
- EPS
- ALDX N/A
- XPOF N/A
- Revenue
- ALDX N/A
- XPOF $316,841,000.00
- Revenue This Year
- ALDX N/A
- XPOF N/A
- Revenue Next Year
- ALDX $43.00
- XPOF $3.45
- P/E Ratio
- ALDX N/A
- XPOF N/A
- Revenue Growth
- ALDX N/A
- XPOF N/A
- 52 Week Low
- ALDX $1.14
- XPOF $6.64
- 52 Week High
- ALDX $7.20
- XPOF $18.87
- Technical
- Relative Strength Index (RSI)
- ALDX 45.98
- XPOF 52.18
- Support Level
- ALDX $5.48
- XPOF $8.10
- Resistance Level
- ALDX $5.88
- XPOF $8.78
- Average True Range (ATR)
- ALDX 0.27
- XPOF 0.36
- MACD
- ALDX -0.07
- XPOF 0.07
- Stochastic Oscillator
- ALDX 1.87
- XPOF 88.71
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About XPOF Xponential Fitness Inc.
Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.